**Compass Pathways Accelerates Potential COMP360 Launch Timeline by 9-12 Months with NDA Submission Plans in Q3 2026**
November 4, 2025 | 11:17 AM ET
Compass Pathways plc (NASDAQ: CMPS) has announced an acceleration in the potential launch timeline for its COMP360 therapy. The company now plans to submit its New Drug Application (NDA) in the third quarter of 2026, advancing the original schedule by approximately 9 to 12 months.
This development highlights Compass Pathways’ commitment to bringing innovative mental health treatments to market more quickly. Investors and stakeholders will be closely watching the company’s progress as it moves towards regulatory approval.
Stay tuned for further updates and detailed insights from Compass Pathways’ upcoming earnings calls.
https://seekingalpha.com/news/4514455-compass-pathways-accelerates-potential-comp360-launch-timeline-by-9-12-months-with-nda?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news